tiprankstipranks
Blurbs

Analysts Conflicted on These Technology Names: Tabula Rasa HealthCare (TRHC) and Infineon Technologies AG (OtherIFNNF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Tabula Rasa HealthCare (TRHCResearch Report) and Infineon Technologies AG (IFNNFResearch Report).

Tabula Rasa HealthCare (TRHC)

SVB Securities analyst Stephanie Davis reiterated a Hold rating on Tabula Rasa HealthCare yesterday and set a price target of $5.50. The company’s shares closed last Tuesday at $5.60.

According to TipRanks.com, Davis is a 1-star analyst with an average return of -3.6% and a 45.5% success rate. Davis covers the Technology sector, focusing on stocks such as NextGen Healthcare, Health Catalyst, and GoodRx Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tabula Rasa HealthCare with a $5.50 average price target.

See the top stocks recommended by analysts >>

Infineon Technologies AG (IFNNF)

UBS analyst Francois Xavier Bouvignies maintained a Buy rating on Infineon Technologies AG today and set a price target of EUR44.00. The company’s shares closed last Tuesday at $34.70.

According to TipRanks.com, Bouvignies is a 4-star analyst with an average return of 11.7% and a 69.8% success rate. Bouvignies covers the Technology sector, focusing on stocks such as NXP Semiconductors, u-blox Holding AG, and ams AG.

Currently, the analyst consensus on Infineon Technologies AG is a Moderate Buy with an average price target of $43.79, a 27.1% upside from current levels. In a report released yesterday, Barclays also upgraded the stock to Buy with a EUR47.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on TRHC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles